Sandbox Clinical Ventures Fund, LP — Form D/A
Sandbox Clinical Ventures Fund, LP of CHICAGO, IL, a pooled investment fund, filed a Form D amendment with the SEC on 2025-02-12. The offering totals $100.0M, of which $72.0M was reported sold. Industry: Pooled Investment Fund.
Offering
- Filed: 2025-02-12
- Form: D/A
- Accession: 0001991620-25-000001
- Industry: Pooled Investment Fund
- Exemptions: 06b, 3C, 3C.7
- Total offering: $100.0M
- Amount sold: $72.0M
- Remaining: $28.0M
- Investors: 10
- Date of first sale: 2023-10-03
- Security types: fund interests
- Revenue range: Not Applicable
- SEC file number: 021-493481
Issuer
- Name: Sandbox Clinical Ventures Fund, LP
- CIK: 0001991620
- Entity type: Limited Partnership
- Jurisdiction: DELAWARE
- Incorporated: 2023
- Address: C/O SANDBOX INDUSTRIES, CHICAGO, IL, 60607
- Phone: 312-243-4100
Officers, directors & promoters (4)
| Name | Role | Location |
|---|
| Matthew Downs | Executive Officer | Chicago, IL |
| Thomas Hawes | Executive Officer | MENLO PARK, CA |
| N/A Sandbox Clinical Ventures, LLC | Executive Officer | Chicago, IL |
| Emir Sandhu | Executive Officer | Chicago, IL |
Other filings by this issuer (1)
More